Clinical Trials Browser

Phase 1/2 × OTHER × abiraterone × Clear all

NCT01848067 2025-05-04

Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Phase 1/2 Completed

9 enrolled 9 charts

Prostatic Neoplasms

NCT01780220 2022-05-19

CARLHA

Phase 1/2 Completed

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy

NCT04839055 2021-04-09

CoA-CRPC

Phase 1/2 Unknown

Castration-resistant Prostate Cancer